Standardized BACTEC method to measure clarithromycin susceptibility of Mycobacterium genavense

Journal of Clinical Microbiology

Volumn 36, Issue 3, 1998, Pages 748-751

  Carlson, La Donna C ^b   Wallis, Carolyn K ^b   Coyle, Marie B ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM GENAVENSE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM SIMIAE; MYCOBACTERIUM XENOPEI; NONHUMAN; PH; PRIORITY JOURNAL; RADIOMETRY;

EID: 0031940471     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.3.748-751.1998     Document Type: Article

References (31)

1. Bessesen, M. T., J. Shlay, B. Stone-Venohr, D. L. Cohn, and R. R. Reves. 1993. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS 7:1357-1361.
2. Böttger, E. C., A. Teske, P. Kirschner, S. Bost, H. R. Chang, V. Beer, and B. Hirschel. 1992. Disseminated Mycobacterium genavense infection in patients with AIDS. Lancet 340:76-80.
3. Carlson, L. C. Unpublished data.
4. Coyle, M. B., L. D. C. Carlson, C. K. Wallis, R. B. Leonard, V. A. Raisys, J. O. Kilburn, M. Samadpour, and E. C. Böttger. 1992. Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J. Clin. Microbiol. 30:3206-3212.
5. Dumonceau, J. M., P.-A. Fonteyne, L. Realini, A. Van Gossum, J.-P. Van Vooren, and F. Portaels. 1995. Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus. J. Clin. Microbiol. 33:2514-2515.
6. Fish, D. N., M. H. Gotfried, L. H. Danzinger, and K. A. Rodvold. 1994. Penetration of clarithromycin into lung tissues from patients undergoing lung resection. Antimicrob. Agents Chemother. 38:876-878.
7. Heifets, L. 1988. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Antimicrob. Agents Chemother. 32:1131-1136.
8. Heifets, L. B. 1996. Clarithromycin against Mycobacterium avium complex infections. Tubercle Lung Dis. 77:19-26.
9. Hirschel, B., H. R. Chang, N. Mach, P. F. Piguet, J. Cox, J. D. Piguet, M. T. Silva, L. Larsson, P. R. Klatser, J. E. R. Thole, L. Rigouts, and F. Portaels. 1990. Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N. Engl. J. Med. 323:109-113.
10. Hoop, R. K., E. C. Böttger, and G. E. Pfyffer. 1996. Etiological agents of mycobacterioses in pet birds between 1986 and 1995. J. Clin. Microbiol. 34:991-992.
11. Inderlied, C. B., and M. Salfinger. 1995. Antimicrobial agents and susceptibility tests: mycobacteria, p. 1385-1404. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
12. Ishiguro, M., H. Koga, T. Hayashi, K. Yamaguchi, and M. Kirota. 1989. Penetration of macrolides into human polymorphonuclear leucocytes. J. Antimicrob. Chemother. 24:719-729.
13. Ji, B., N. Lounis, C. Truffot-Pernot, and J. Grosset. 1992. Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. Antimicrob. Agents Chemother. 36:2839-2840.
14. Kiehn, T. E., H. Hoefer, E. C. Böttger, R. Ross, M. Wong, F. Edwards, N. Antinoff, and D. Armstrong. 1996. Mycobacterium genavense infections in pet animals. J. Clin. Microbiol. 34:1840-1842.
15. Liberek, V., C. Soravia, B. Ninet, B. Hirschel, and C. A. Siegrist. 1996. Cervical lymphadenitis caused by Mycobacterium genavense in a healthy child Pediatr. Infect. Dis. J. 15:269-270.
16. Matsiota-Bernard, P., D. Thierry, P. De Truchis, M. Saillour, F. Paraire, J. L. Guesdon, and C. Nauciel. 1995. Mycobacterium genavense infection in a patient with AIDS who was successfully treated with clarithromycin. Clin. Infect. Dis. 20:1565-1566.
17. Meier, A., L. Heifets, R. J. Wallace, Jr., Y. Zhang, B. Brown, P. Sander, and E. C. Bottger. 1996. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J. Infect. Dis. 174:354-360.
18. Mor, N., J. Vanderkolk, and L. Heifets. 1994. Accumulation of clanthromycin in macrophages infected with Mycobacterium avium. Pharmacotherapy 14:100-104.
19. Nadal, D., R. Caduff, R. Kraft, M. Salfinger, T. Bodmer, P. Kirschner, E. C. Böttger and U. B. Schaad. 1993. Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 12:37-43.
20. Nash, K. A., and C. B. Inderlied. 1995. Genetic basis of macrolide resistance in Mycobacterium avium isolated in patients with disseminated disease. Antimicrob. Agents Chemother. 39:2625-2630.
21. Nolte, F. S., and B. Metchock. 1995. Mycobacterium, p. 400-437. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
22. Pechére, M., M. Opravil, A. Wald, J. P. Chave, M. Bessesen, A. Sievers, R. Hein, J. von Overbeck, R. A. Clark, E. Tortoli, S. Emler, P. Kirschner, V. Gabriel, E. C. Böttger, and B. Hirschel. 1995. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch. Intern. Med. 155:400-404.
23. Portaels, F., L. Realini, L. Bauwens, B. Hirschel, W. M. Meyers, and W. De Meurichy. 1996. Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey. J. Clin. Microbiol. 34:319-323.
24. Rastogi, N., R.-M. Bauriaud, A. Bourgoin, B. Carbonnelle, C. Chippaux, M.-J. Gevaudan, K. S. Goh, D. Moinard, and P. Roos. 1995. French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex. Antimicrob. Agents Chemother. 39:638-644.
25. Rastogi, N., and K. S. Goh. 1992. Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. Antimicrob. Agents Chemother. 36:2841-2842.
26. Siddiqi, S. H. Personal communication.
27. Siddiqi, S. H., L. B. Heifets, M. H. Cynamon, N. M. Hooper, A. Laszlo, J. P. Libonati, P. J. Lindholm-Levy, and N. Pearson. 1993. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J. Clin. Microbiol. 31:2332-2338.
28. Siddiqi, S. H., A. Laszlo, W. R. Butler, and J. O. Kilburn. 1993. Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients Diagn. Microbiol. Infect. Dis. 16:321-323.
29. Stracher, A. R., and K. A. Sepkowitz. 1995. Atypical mycobacterial infections in HIV disease. AIDS Reader 1995(Jan/Feb.):14-25.
30. Tortoli, E., M. S. Tullia, D. Dionisio, and M. Meli. 1994. Cultural studies on two isolates of "Mycobacterium genavense" from patients with acquired immunodeficiency syndrome. Diagn. Microbiol. Infect. Dis. 18:7-12.
31. Wald, A., M. B. Coyle, L. C. Carlson, R. L. Thompson, and T. M. Hooton. 1992. Infection with a fastidious mycobacterium resembling Mycobacterium simiae in seven patients with AIDS. Ann. Intern. Med. 117:586-589.